Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Remes

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Acta Haematologica|June 12, 2026
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data CollectionJohanna Vikkula, Kari Remes, Outi Laatikainen, et al.
Haematologica|April 12, 2005
Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patientsMervi Putkonen, Auvo Rauhala, Maija Itälä, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2012
[Stem cell transplantation in myelofibrosis]Aura Toivari, Maija Itälä-Remes, Marjut Kauppila, et al.
European Journal of Haematology|May 21, 2003
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-studyBo Björkstrand, Thomas Rasmussen, Kari Remes, et al.
European Journal of Haematology|August 21, 2010
Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myelomaMervi Putkonen, Veli Kairisto, Vesa Juvonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
Treatment of adult acute myeloid leukemiaJoni Järvenpää, Maija Itälä-Remes, Tommi Kauko, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 30, 2014
[Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS]Rami Nylund, Maija Itälä-Remes, Tommi Kauko, et al.
Blood|August 30, 2002
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantationTapani Ruutu, Britta Eriksson, Kari Remes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized studyTapani Ruutu, Eeva Juvonen, Mats Remberger, et al.
Haematologica|September 24, 2016
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationJohan Törlén, Olle Ringdén, Karin Garming-Legert, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Acta Haematologica|June 12, 2026
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data CollectionJohanna Vikkula, Kari Remes, Outi Laatikainen, et al.
Haematologica|April 12, 2005
Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patientsMervi Putkonen, Auvo Rauhala, Maija Itälä, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 14, 2012
[Stem cell transplantation in myelofibrosis]Aura Toivari, Maija Itälä-Remes, Marjut Kauppila, et al.
European Journal of Haematology|May 21, 2003
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-studyBo Björkstrand, Thomas Rasmussen, Kari Remes, et al.
European Journal of Haematology|August 21, 2010
Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myelomaMervi Putkonen, Veli Kairisto, Vesa Juvonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
Treatment of adult acute myeloid leukemiaJoni Järvenpää, Maija Itälä-Remes, Tommi Kauko, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 30, 2014
[Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS]Rami Nylund, Maija Itälä-Remes, Tommi Kauko, et al.
Blood|August 30, 2002
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantationTapani Ruutu, Britta Eriksson, Kari Remes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized studyTapani Ruutu, Eeva Juvonen, Mats Remberger, et al.
Haematologica|September 24, 2016
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationJohan Törlén, Olle Ringdén, Karin Garming-Legert, et al.
Pageof 4